CBS News Covers AXIM Biotech’s Patent Filing for Controlled-Release Chewing Gum to Provide Treatment for Opioid Addiction
February 21, 2018 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) --
AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTCQB:AXIM), a world leader in cannabinoid research and development, today announced that CBS News...
Court Date Set for Worlds Inc.’s IPR Appeal Oral Argument
January 25, 2018 08:00 ET
|
Worlds Inc.
BOSTON, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Worlds Inc. (OTCQB:WDDD) announced that on January 22, 2018, the United States Court of Appeals for the Federal Circuit scheduled the oral argument for...
Voip-Pal Issues a Correction to its Press Release of September 18th 2017
January 11, 2018 22:36 ET
|
Voip-Pal.Com Inc.
BELLEVUE, Wash., Jan. 11, 2018 (GLOBE NEWSWIRE) -- Voip-Pal.com, Inc. (“Voip-Pal,” the “Company”) (OTCQB:VPLM) has posted a series of letters authored by former Chairman and CEO, Dr. Thomas Sawyer,...
PROVECTUS BIOPHARMACEUTICALS RECEIVES THIRD CANCER COMBINATION THERAPY PATENT FROM THE UNITED STATES PATENT AND TRADEMARK OFFICE
December 14, 2017 06:00 ET
|
Provectus Biopharmaceuticals Inc.
– Protection expands coverage for combinations of intralesional PV-10 with checkpoint inhibitors for multiple solid tumor cancers – KNOXVILLE, TN, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Provectus...
New U.S. Patent Allowance Granted to AXIM® Biotechnologies, Inc. for Cannabinoid Ophthalmic Solutions for Glaucoma and Conjunctivitis Treatment
October 05, 2017 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, Oct. 05, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech), (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the United States...
Voip-Pal.Com Posts Letters from Former Chairman, Dr. Thomas Sawyer on Company Website
September 18, 2017 05:00 ET
|
Voip-Pal.Com Inc.
BELLEVUE, Wash., Sept. 18, 2017 (GLOBE NEWSWIRE) -- Voip-Pal.com, Inc. (“Voip-Pal,” the “Company”) (OTCQB:VPLM) has posted a series of letters authored by former Chairman and CEO, Dr. Thomas...
AXIM Biotech Files Patent on Controlled Release Chewing Gum to Provide Opioid Addiction Treatment
June 23, 2017 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, June 23, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company filed with...
Worlds Files Appeal to Federal Circuit on PTAB Rulings, Claims Related to Patent Trial
May 22, 2017 08:30 ET
|
Worlds Inc.
BOSTON, May 22, 2017 (GLOBE NEWSWIRE) -- Worlds Inc. (OTCQB:WDDD) has filed an appeal brief to recent Patent Trial and Appeal Board (PTAB) rulings with the United States Court of Appeals for...
New U.S. Patent Allowance Granted to AXIM® Biotech for Use of All Cannabinoids in Its Controlled-Release Chewing Gum Products
November 16, 2016 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, Nov. 16, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in hemp cannabinoid research and development, today announced that the United...
John Marshall Law School IP Program Hosts Chief Judges Sharon Prost and Ruben Castillo to Discuss the Courts and Case Management in Patent Litigation
April 25, 2016 17:28 ET
|
The John Marshall Law School-Chicago
CHICAGO, April 25, 2016 (GLOBE NEWSWIRE) -- The John Marshall Law School in Chicago will co-host the Federal Circuit Bar Association's conference "Patent Litigation 2016: The Courts and the Patent...